{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:12:38Z","timestamp":1770509558802,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s14208","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:09:55Z","timestamp":1309997395000},"page":"409","source":"Crossref","is-referenced-by-count":3,"title":["Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures"],"prefix":"10.2147","author":[{"given":"Michael","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,7]]},"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=10488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:10:21Z","timestamp":1477851021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/profile-of-ezogabine-retigabine-and-its-potential-as-an-adjunctive-tre-peer-reviewed-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ndt.s14208","relation":{},"ISSN":["1176-6328"],"issn-type":[{"value":"1176-6328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}